A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

PHASE2CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

May 16, 2023

Study Completion Date

May 16, 2023

Conditions
Alopecia Areata
Interventions
DRUG

CTP-543

Oral dosing

DRUG

Placebo

Oral dosing

Trial Locations (39)

15241

PEAK Research, LLC, Upper Saint Clair

19462

Dermatology Associates of Plymouth Meeting, Plymouth Meeting

23233

West End Dermatology Associates, Richmond

27617

North Carolina Dermatology Associates, PLLC, Raleigh

28277

Darst Dermatology, Charlotte

Dermatology Specialists of Charlotte, Charlotte

29407

Clinical Research Center of the Carolinas, Charleston

33021

Skin Care Research, LLC, Hollywood

33486

Skin Care Research, LLC, Boca Raton

35205

Total Skin and Beauty Dermatology Center, PC, Birmingham

40241

DS Research, Louisville

43209

Bexley Dermatology Research, Bexley

43215

Remington Davis, Columbus

46168

The Indiana Clinical Trials Center, PC, Plainfield

48346

Michigan Center for Research Company, LLC, Clarkston

55112

Minnesota Clinical Study Center, New Brighton

55455

University of Minnesota Department of Dermatology, Minneapolis

60611

DeNova Research, Chicago

68144

Skin Specialists, PC, Omaha

74136

Vital Prospects Clinical Research Institute, PC, Tulsa

75230

Dermatology Treatment and Research Center, PA, Dallas

77056

Austin Institute for Clinical Research, Houston

78660

Austin Institute for Clinical Research, Inc., Pflugerville

80111

Colorado Center for Dermatology and Skin Surgery, Centennial

80210

Colorado Medical Research Center, Inc., Denver

84663

Springville Dermatology/CCT Research, Springville

85260

Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale

91303

Hope Clinical Research, Canoga Park

91324

Quest Dermatology Research, Northridge

92024

California Dermatology & Clinical Research Institute, Encinitas

92262

Palmtree Clinical Research, Inc., Palm Springs

92697

University of California, Irvine, Irvine

93301

Kern Research, Inc., Bakersfield

94118

Kaiser Permanente, San Francisco

94611

Kaiser Permanente, Oakland

97210

Northwest Dermatology, Portland

06519

Yale University Church Street Research Unit, New Haven

07601

Skin Laser and Surgery Specialists of New Jersey, Hackensack

02903

Rhode Island Hospital, Providence

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT04784533 - A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata | Biotech Hunter | Biotech Hunter